Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867)
China flag China · Delayed Price · Currency is CNY
8.93
-0.04 (-0.45%)
Nov 13, 2024, 3:00 PM CST

Tonghua Dongbao Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
17,40721,48318,21022,16126,99925,730
Upgrade
Market Cap Growth
-18.34%17.97%-17.83%-17.92%4.93%-8.99%
Upgrade
Enterprise Value
17,53220,92116,96621,32126,74125,526
Upgrade
Last Close Price
8.9310.568.759.8611.8311.04
Upgrade
PE Ratio
55.9517.9011.0715.4025.7227.60
Upgrade
PS Ratio
7.856.996.556.789.349.26
Upgrade
PB Ratio
2.712.982.783.564.865.14
Upgrade
P/FCF Ratio
233.6241.8449.1938.2337.8829.95
Upgrade
P/OCF Ratio
28.3324.9421.1018.7722.6522.33
Upgrade
EV/Sales Ratio
7.216.806.116.529.259.19
Upgrade
EV/EBITDA Ratio
22.8214.3816.4215.3520.5823.31
Upgrade
EV/EBIT Ratio
31.4116.4719.2317.1223.3627.09
Upgrade
EV/FCF Ratio
235.2940.7545.8336.7837.5229.71
Upgrade
Debt / Equity Ratio
0.080.020.000.000.000.03
Upgrade
Debt / EBITDA Ratio
0.640.100.000.000.000.12
Upgrade
Debt / FCF Ratio
6.610.290.010.000.000.15
Upgrade
Asset Turnover
0.340.420.420.530.520.51
Upgrade
Inventory Turnover
0.740.911.051.091.000.95
Upgrade
Quick Ratio
2.323.928.165.816.404.16
Upgrade
Current Ratio
4.305.4112.698.059.236.32
Upgrade
Return on Equity (ROE)
5.14%16.97%24.77%22.22%17.61%16.62%
Upgrade
Return on Assets (ROA)
4.87%10.93%8.31%12.63%12.83%10.89%
Upgrade
Return on Capital (ROIC)
5.02%11.41%8.63%13.21%13.37%11.41%
Upgrade
Earnings Yield
1.79%5.44%8.69%5.90%3.44%3.15%
Upgrade
FCF Yield
0.43%2.39%2.03%2.62%2.64%3.34%
Upgrade
Dividend Yield
2.79%2.37%5.72%3.04%1.77%1.81%
Upgrade
Payout Ratio
147.41%42.49%69.27%32.49%43.40%50.15%
Upgrade
Buyback Yield / Dilution
-6.93%1.15%2.04%-1.12%0.32%0.85%
Upgrade
Total Shareholder Return
-4.15%3.52%7.76%1.93%2.09%2.66%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.